Amarin Corp Plc (AMRN)

[HDGabor]

Update to 337-TA-3247:

621611 - Amarin - Exhibits (FOLDER), 08/30/2017 11:39 AM, Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.

621633 - Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest, 08/30/2017 02:16 PM, Office of the Secretary

622365 - F.R. Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest, 09/06/2017 05:00 PM, Office of the Secretary

623030 - Amarin - Revised Public Exhibits (FOLDER), 09/14/2017 11:44 AM, Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.

623041 - Public Interest Comments, 09/14/2017 12:38 PM, Hale Oswick Family and Friends

623534 - Amarin - Amended Exhibit 70 to the Complaint (Exhibit 70), 09/21/2017 04:49 PM, Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.

337-TA-3247 submitted (public) documents
I will update the folder if new documents will be available.

Best,
G

Amended Exhibit 70 to the Complaint
Doc Id: 623534 2 Files Details (2 Files) (Public)
Investigation: 337-3247 Violation Doc Type: Complaint
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/21/2017 04:49 PM
Filed By: Jeffrey M. Telep of King and Spalding
On Behalf Of: Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.
[File ID: 1229839] - KING King & Spalding LLP 8c SPALDING 1,0, ,,,,,,,,,,,,,,.,A,,, NW ' i ' Washington, D.C. 20006-4707 l
- Tel: [phone] Faxf [phone] www.kslaw.com _ September 21 , 2017 Kevin M. Dinan Direct Dial: 202
661-7916 [e-mail] - . . VIA HAND DELIVERY Hon. Rhonda K. Schmidtlein Chairman U.S. International Trade
Commission 500 E Street, NW, Room 112 Washington, DC 20436 Re: ' Certain Svntheticallv Produced. Predominantly
EPA Omega-3 Products In Ethvl Ester Or Re-est

Amended Exhibit 70 to the Complaint
Doc Id: 623533 2 Files Details (2 Files) (Confidential)
Investigation: 337-3247 Violation Doc Type: Complaint
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/21/2017 04:49 PM
Filed By: Jeffrey M. Telep of King and Spalding
On Behalf Of: Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.
[File ID: 1229841] - Not authorized to view.

Request Not to Institute and Brief on Jurisdiction of Respondents DSM and Pharmavite
Doc Id: 623336 2 Files Details (2 Files) (Public)
Investigation: 337-3247 Violation Doc Type: Action Request
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/18/2017 04:46 PM
Filed By: Jordan L. Coyle of Orrick, Herrington & Sutcliffe LLP
On Behalf Of: Respondents Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM
Nutritional Products Canada, Inc., and Pharmavite LLC
[File ID: 1226616] - UNITED STATES INTERNATIONAL TRADE COMMISSION WASHINGTON, D.C. 20436 In the
Matter of CERTAIN SYNTHETICALLY PRODUCED, PREDOMINANTLY EPA OMEGA-3 PRODUCTS IN ETHYL
ESTER OR RE-ESTERIFIED TRIGLYCERIDE FORM Docket No. 3247 BRIEF ON JURISDICTION OF RESPONDENTS
DSM AND PHARMAVITE In response to the Brief on Jurisdiction filed by Complainants Amarin Pharma, Inc. and Amarin
Pharmaceuticals Ireland Ltd. (collectively “Amarin”), Respondents Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM
Nutritional

Complainant's Reply Comments on the Public Interest
Doc Id: 623313 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Comments/Response to Comments
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/18/2017 02:53 PM
Filed By: Jeffrey M. Telep of King and Spalding
On Behalf Of: Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.
[File ID: 1226518] - UNITED STATES INTERNATIONAL TRADE COMMISSION WASHINGTON, D.C. In tlte Matter of
Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-esterified Triglyceride Form
) ) ) Investigation No. 337-TA-3247 ) ) ) ) COMPLAINANTS' REPLY COMMENTS ON THE PUBLIC INTEREST
Respectfully submitted, Jeffrey M. Telep Lisa M. Dwyer David J . Farber Kevin M. Dinan Patrick J. Togni Elizabeth E.
Owerbach KING & SPALDING L LP 1700 Pennsylvania Avenue, NW Suite 200 Washington, DC

Council for Responsible Nutrition Public Interest Comments
Doc Id: 623140 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Comments/Response to Comments
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 05:11 PM
Filed By: Deanna Tanner Okun of Adduci, Mastriani and Schaumberg
On Behalf Of: Council for Responsible Nutrition
[File ID: 1226133] - No text to view.

Response to Commission's Request for Comments on Public Interest
Doc Id: 623138 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Comments/Response to Comments
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 05:09 PM
Filed By: Andrew F. Pratt of Venable LLP
On Behalf Of: Nordic Naturals and Nordic Pharma, Inc.
[File ID: 1226127] - No text to view.

Statement of The Consumer Healthcare Products Association on Solicitation of Public Interest
Doc Id: 623134 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Comments/Response to Comments
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 04:59 PM
Filed By: Jay Sirois of Consumer Healthcare Products Association
On Behalf Of: Consumer Healthcare Products Association
[File ID: 1226117] - No text to view.

Letter to Chairman Rhonda K. Schmidtlein in Support of Request Not to Institute
Doc Id: 623113 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Action Request
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 04:13 PM
Filed By: Joseph Cwik of Amin Talati Upadhye LLP
On Behalf Of: Global Organization for EPA and DHA Omega
[File ID: 1226027] - No text to view.

Global Organization for EPA and DHA Omega Public Interest Statement
Doc Id: 623111 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Comments/Response to Comments
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 04:12 PM
Filed By: Joseph Cwik of Amin Talati Upadhye LLP
On Behalf Of: Global Organization for EPA and DHA Omega
[File ID: 1226025] - No text to view.

Statement of Respondents DSM and Pharmavite Concerning the Public Interest
Doc Id: 623099 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Comments/Response to Comments
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 04:02 PM
Filed By: Jordan L. Coyle of Orrick, Herrington & Sutcliffe LLP
On Behalf Of: Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products LLC, DSM Nutritional Products
Canada, Inc., and Pharmavite LLC
[File ID: 1226013] - No text to view.

Letter to Chairman Rhonda K. Schmidtlein Requesting the Complaint Not Be Instituted
Doc Id: 623080 2 Files Details (2 Files) (Public)
Investigation: 337-3247 Violation Doc Type: Action Request
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 02:57 PM
Filed By: Deanna Tanner Okun of Adduci, Mastriani and Schaumberg
On Behalf Of: Council for Responsible Nutrition
[File ID: 1225936] - No text to view.

Public Interest Comments
Doc Id: 623041 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Comments/Response to Comments
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 12:38 PM
Filed By: Jennifer Hale of Jennifer Hale
On Behalf Of: Hale Oswick Family and Friends
[File ID: 1225832] - No text to view.

Supplemental Letter with Revised Confidential Exhibits
Doc Id: 623031 7 Files Details (7 Files) (Confidential)
Investigation: 337-3247 Violation Doc Type: Complaint
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 11:44 AM
Filed By: Jeffrey M. Telep of King & Spalding
On Behalf Of: Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.
[File ID: 1225975] - Not authorized to view.

Supplemental Letter with Revised Public Exhibits
Doc Id: 623030 27 Files Details (27 Files) (Public)
Investigation: 337-3247 Violation Doc Type: Complaint
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/14/2017 11:44 AM
Filed By: Jeffrey M. Telep of King & Spalding
On Behalf Of: Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.
[File ID: 1225961] - No text to view.

F.R. Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
Doc Id: 622365 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Notice
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 09/06/2017 05:00 PM
Filed By: Lisa A. Barton of USITC
On Behalf Of: Office of the Secretary
[File ID: 1224206] - 42114 Federal Register / Vol. 82, No. 171 / Wednesday, September 6, 2017 / Notices value
(‘‘LTFV’’) and to be subsidized by the government of China. Commencement of Final Phase Investigations Pursuant to
section 207.18 of the Commission’s rules, the Commission also gives notice of the commencement of the final phase of
its investigations. The Commission will issue a final phase notice of scheduling, which will be published in the Federal
Register as provided in section 207.21 of the Commission

Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
Doc Id: 621633 1 File Details (1 File) (Public)
Investigation: 337-3247 Violation Doc Type: Notice
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 08/30/2017 02:16 PM
Filed By: Lisa R. Barton of USITC
On Behalf Of: Office of the Secretary
[File ID: 1221632] - UNITED STATES INTERNATIONAL TRADE COMMISSION Washington, DC NOTICE OF RECEIPT
OF COMPLAINT; SOLICITATION OF COMMENTS RELATING TO THE PUBLIC INTEREST AGENCY: U.S.
International Trade Commission. ACTION: Notice. SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has received a complaint entitled Certain Synthetically Produced, Predominantly EPA Omega-3 Products in
Ethyl Ester or Re-esterified Triglyceride Form, DN 3247; the Commission is soliciting comments on any public

Complaint and Exhibits
Doc Id: 621611 36 Files Details (36 Files) (Public)
Investigation: 337-3247 Violation Doc Type: Complaint
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 08/30/2017 11:39 AM
Filed By: Jeffrey M. Telep of King and Spalding
On Behalf Of: Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.
[File ID: 1221634] - KING 1700 Pennsylvania Avenue, N.W. 8c SPALDING washingt0n!DC20006_4706 ' [phone]
(telephone) [phone] (fax) www.kslaw.com ‘ i '1 DOCKEI . NUMBER August 30, 3017 The Honorable Lisa R.
Barton » i Secretary . U.S. Intemational Trade Commission 500 E Street, sw, Room 112A Washington, Re: 7 --------.-. ----
--7 ................... .. 0“'°° 0' "19 , , Swetaw I '"" ""*°°C°"*'"i$§ifl" DC 20436 In the Matter of Certain Synthetically Produced,
Predominantly EPA Omega-3 Produc

Confidential Exhibits
Doc Id: 621610 9 Files Details (9 Files) (Confidential)
Investigation: 337-3247 Violation Doc Type: Complaint
Inv Title: Certain Synthetically Produced, Predominantly EPA Omega-3 Products In Ethyl Ester Or Re-Esterified Triglyceride
Form, DN 3247
Official Receive Date: 08/30/2017 11:39 AM
Filed By: Jeffrey M. Telep of King and Spalding
On Behalf Of: Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd.
[File ID: 1221674] - Not authorized to view.